Patents by Inventor Yao-tseng Chen

Yao-tseng Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer
    Patent number: 6043084
    Abstract: Various molecules associated with disorders such as colon cancer are disclosed. The invention also discloses diagnostic and therapeutic methods based upon these molecules.
    Type: Grant
    Filed: October 10, 1997
    Date of Patent: March 28, 2000
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Yao-Tseng Chen, Elisabeth Stockert, Lloyd J. Old
  • Tumor rejection antigen precursor
    Patent number: 5843448
    Abstract: The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule MAGE-1, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of MAGE-1, peptides which are useful as immunogens, and immunogenic compositions containing the peptides and an adjuvant.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: December 1, 1998
    Assignee: Ludwig Institute of Cancer Research
    Inventors: Yao-Tseng Chen, Elisabeth Stockert, Yachi Chen, Pilar Garin-Chesa, Wolfgang J. Rettig, Lloyd J. Old
  • Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
    Patent number: 5804381
    Abstract: The invention relates to the isolation of a nucleic acid molecule which encodes an esophageal cancer associated antigen. Also a part of the invention is the antigen itself, and the uses of the nucleic acid molecule and the antigen.
    Type: Grant
    Filed: October 3, 1996
    Date of Patent: September 8, 1998
    Assignees: Cornell Research Foundation, Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center
    Inventors: Yao-tseng Chen, Matthew Scanlan, Ali Gure, Lloyd J. Old
  • Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
    Patent number: 5674749
    Abstract: The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule Melan-A, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of Melan-A and immunogenic compositions containing the molecules, and an adjuvant.
    Type: Grant
    Filed: March 26, 1996
    Date of Patent: October 7, 1997
    Assignees: Ludwig Institute For Cancer Research, Memorial Sloan Kettering Cancer Center, Cornell Research Foundation, Inc.
    Inventors: Yao-tseng Chen, Elisabeth Stockert, Achim Jungbluth, Lloyd J. Old
  • Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1
    Patent number: 5541104
    Abstract: The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule MAGE-1, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of MAGE-1, peptides which are useful as immunogens, and immunogenic compositions containing the peptides and an adjuvant.
    Type: Grant
    Filed: February 1, 1994
    Date of Patent: July 30, 1996
    Assignees: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Yao-Tseng Chen, Elisabeth Stockert, Yachi Chen, Pilar Garin-Chesa, Wolfgang J. Rettig, Pierre van der Bruggen, Thierry Boon-Falleur, Lloyd J. Old